We are live on ! Find out more
FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Fund
S&P 500
This Quarter Est. Return
+53.1%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
AUM
$39.5M
AUM Growth
-$9.98M
Cap. Flow
-$30.4M
Cap. Flow %
-76.79%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$30.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXG icon
1
10x Genomics
TXG
$5.87B
$39.5M 100%
708,528
-650,000
-48% -$30.4M

Similar funds

Foresite Capital Management II's Q1 2023 Portfolio in Review

As of Q1 2023, Foresite Capital Management II held 1 position worth $39.5M, down 20% from $49.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management II withdrew a net $30.4M in Q1 2023, reducing 1 holding. Its largest reduction was 10x Genomics, cutting an estimated $30.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Foresite Capital Management II's biggest Q1 2023 reduction was 10x Genomics, cutting an estimated $30.4M.
  • Foresite Capital Management II's ten largest holdings make up 100% of its $39.5M portfolio in Q1 2023.
  • Foresite Capital Management II opened 0 new positions and closed 0 in Q1 2023.
  • Foresite Capital Management II's portfolio value fell 20% quarter-over-quarter to $39.5M.

Based on Foresite Capital Management II's 13F filing for Q1 2023, filed 12 May 2023.